Evidence map›Paper›PMID 32925091›Full record

ArticleJournal of neuromuscular diseases2020

Neuroanatomical Models of Muscle Strength and Relationship to Ambulatory Function in Spinal Muscular Atrophy.

Rafael Rodriguez-Torres, Julia Fabiano, Ashley Goodwin, Ashwini K Rao, Stacy Kinirons, Darryl De Vivo, Jacqueline Montes

2 registry-linked trialsOpen access · greenAbstract readClinical Study
In one paragraph

Article in Journal of neuromuscular diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact, top 87% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01166022 nacompletednot on this map

Randomized, Controlled Clinical Trial of Exercise in Patients With Spinal Muscular Atrophy (SMA)

TypeinterventionalSponsorColumbia UniversityRan2010 to 2014Enrolled14ConditionsSpinal Muscular Atrophy, Neuromuscular DiseaseArmsExercise
NCT02895789 completednot on this map

Evaluation of Oxidative Capacity and Exercise Tolerance in Ambulatory Patients With Spinal Muscular Atrophy (SMA)

TypeobservationalSponsorColumbia UniversityRan2016 to 2021Enrolled42ConditionsSpinal Muscular Atrophy Type 3, Mitochondrial Myopathy
3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Rafael Rodriguez-TorresDepartment of Rehabilitation and Regenerative Medicine, Columbia University Irving Medical Center, New York, NY, USA.
Julia FabianoDepartment of Rehabilitation and Regenerative Medicine, Columbia University Irving Medical Center, New York, NY, USA.
Ashley GoodwinDepartment of Rehabilitation and Regenerative Medicine, Columbia University Irving Medical Center, New York, NY, USA.
Ashwini K RaoDepartment of Rehabilitation and Regenerative Medicine, Columbia University Irving Medical Center, New York, NY, USA.
Stacy KinironsDepartment of Rehabilitation and Regenerative Medicine, Columbia University Irving Medical Center, New York, NY, USA.
Darryl De VivoDepartment of Neurology, Columbia University Irving Medical Center, New York, NY, USA.
Jacqueline MontesDepartment of Rehabilitation and Regenerative Medicine, Columbia University Irving Medical Center, New York, NY, USA.
Columbia University Irving Medical Center · US

Funding

Evaluation of Oxidative Capacity and Exercise Tolerance in Ambulatory Patients with Spinal Muscular AtrophyK01HD084690 · NICHD · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MONTES, JACQUELINE · 2016 to 2020
$651k
NICHD NIH HHS K01 HD084690
6 · The paper itself

Abstract

backgroundIndividuals with spinal muscular atrophy (SMA) III walk independently, but experience muscle weakness, gait impairments, and fatigue. Although SMA affects proximal more than distal muscles, the characteristic pattern of selective muscle weakness has not been explained. Two theories have been proposed: 1) location of spinal motor neurons; and 2) differences in segmental innervation.

objectiveTo identify neuroanatomical models that explain the selective muscle weakness in individuals with SMA and assess the relationship of these models to ambulatory function.

methodsData from 23 ambulatory SMA participants (78.2% male), ages 10-56 years, enrolled in two clinical studies (NCT01166022, NCT02895789) were included. Strength was assessed using the Medical Research Council (MRC) score; ambulatory function was measured by distance walked on the 6-minute walk test (6 MWT). Three models were identified, and relationships assessed using Pearson correlation coefficients and linear regression.

resultsAll models demonstrated a positive association between strength and function, (p < 0.02). Linear regression revealed that Model 3B, consisting of muscles innervated by lower lumbar and sacral segments, explained 67% of the variability observed in 6 MWT performance (β= 0.670, p = 0.003).

conclusionsMuscles innervated by lower lumbar and sacral segments, i.e. hip extensors, hip abductors, knee flexors and ankle dorsiflexors, correlated with and predicted greater ambulatory function. The neuroanatomical patterns of muscle weakness may contribute to a better understanding of disease mechanisms and enable delivery of targeted therapies.

Indexed as

AdolescentAdultChildExercise TestFemaleGait Disorders, NeurologicHumansMaleMiddle AgedMobility LimitationModels, NeurologicalMuscle, SkeletalMuscle WeaknessMuscular Atrophy, SpinalYoung Adultmuscle weaknessSpinal muscular atrophystrengthwalkingwalk test

Identifiers

PMID32925091
PMCPMC9344600
OpenAlexW3087724245

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.